| CAT No: | CL-PRS-02 |
| CAS No: | NA |
| Mol.F: | C2413C3H32FN715N2O2 |
| Mol.Wt.: | 538.6 |
| Rel. Cas No: | |
| Chemical Name: | (1s,4R)-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-(methyl-13C)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl-2,5-13C2-1,3-15N2)cyclohexane-1-carboxamide |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Pralsetinib-13C3-15N2 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Pralsetinib-13C3-15N2 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(1s,4R)-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-(methyl-13C)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl-2,5-13C2-1,3-15N2)cyclohexane-1-carboxamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Pralsetinib Molecular Formula: C2413C3H32FN715N2O2
Molecular Weight: 538.6
Storage: Store in a cool, dry place.
| Product Name: | Pralsetinib-13C3-15N2 |
| CAS No: | |
| Mol.F.: | C2413C3H32FN715N2O2 |
| Mol.Wt.: | 538.6 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: